CLARA WEAVER: Open Payments
NPI 1245970086 · CLARKSVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$865 in 43 payments from 12 companies in 2025. Trend: 2023 $572 · 2024 $1,674 · 2025 $865
Food & beverage: $865
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $281 |
| GlaxoSmithKline, LLC. | 7 | $120 |
| GENZYME CORPORATION | 4 | $109 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $70 |
| Novartis Pharmaceuticals Corporation | 3 | $60 |
| Amgen Inc. | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Grifols USA, LLC | 2 | $37 |
| Cycle Pharmaceuticals Inc | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
Products named: FASENRA, DUPIXENT, TEZSPIRE, NUCALA, NEFFY, AIRSUPRA, EOHILIA, Xembify.
Industry payments across TN — which companies pay providers there.
